Passantino Andrea, Monitillo Francesco, Iacoviello Massimo, Scrutinio Domenico
Andrea Passantino, Domenico Scrutinio, Division of Cardiology and Cardiac Rehabilitation, "S. Maugeri" Foundation, IRCCS, Institute of Cassano Murge, 70020 Bari, Italy.
World J Cardiol. 2015 Dec 26;7(12):902-11. doi: 10.4330/wjc.v7.i12.902.
Acute heart failure is a leading cause of hospitalization and death, and it is an increasing burden on health care systems. The correct risk stratification of patients could improve clinical outcome and resources allocation, avoiding the overtreatment of low-risk subjects or the early, inappropriate discharge of high-risk patients. Many clinical scores have been derived and validated for in-hospital and post-discharge survival; predictive models include demographic, clinical, hemodynamic and laboratory variables. Data sets are derived from public registries, clinical trials, and retrospective data. Most models show a good capacity to discriminate patients who reach major clinical end-points, with C-indices generally higher than 0.70, but their applicability in real-world populations has been seldom evaluated. No study has evaluated if the use of risk score-based stratification might improve patient outcome. Some variables (age, blood pressure, sodium concentration, renal function) recur in most scores and should always be considered when evaluating the risk of an individual patient hospitalized for acute heart failure. Future studies will evaluate the emerging role of plasma biomarkers.
急性心力衰竭是住院和死亡的主要原因,并且给医疗保健系统带来日益沉重的负担。对患者进行正确的风险分层可改善临床结局并优化资源分配,避免对低风险患者过度治疗或对高风险患者过早、不恰当地出院。许多临床评分已被推导并验证用于住院期间和出院后的生存情况;预测模型包括人口统计学、临床、血流动力学和实验室变量。数据集来自公共登记处、临床试验和回顾性数据。大多数模型显示出良好的区分达到主要临床终点患者的能力,C指数通常高于0.70,但它们在现实人群中的适用性很少得到评估。尚无研究评估基于风险评分的分层使用是否可能改善患者结局。一些变量(年龄、血压、钠浓度、肾功能)在大多数评分中反复出现,在评估因急性心力衰竭住院的个体患者风险时应始终予以考虑。未来的研究将评估血浆生物标志物的新作用。